# Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/brivanib-as-adjuvant-therapy-to-transarterial-chemoembolization-in-patients-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Masatoshi Kudo,Guohong Han,Richard S. Finn,Ronnie T.P. Poon,Jean‐Frédéric Blanc,Lünan Yan,Jijin Yang,Ligong Lu,Won Young Tak,Xiaoping Yu,Joon-Hyeok Lee,Shi‐Ming Lin,Changping Wu,Tawesak Tanwandee,Guoliang Shao,Ian Walters,Christine Dela Cruz,Valerie Poulart,Jianhua Wang |
| Citations | 352 |
| DOI | 10.1002/hep.27290 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1633413258 |
| PMID | 24996197 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Ligong Lu](https://scholariq.org/researchers/ligong-lu/)

## Paper primary topic

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

## Paper topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Fibroblast Growth Factor Research](https://scholariq.org/topics/fibroblast-growth-factor-research/)
- [Liver physiology and pathology](https://scholariq.org/topics/liver-physiology-and-pathology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.